ELTON

Why every product release is its own cybersecurity lifecycle

The same CVE in three different releases of your product can carry three different ratings, and all three can be correct. That is not a bug in the process. It is the point. A vulnerability's severity depends on the architecture, the controls, and the attack surface of the specific release it lands in.

v1.2local · 3.1v2.0blocked · N/Av2.4network · 8.6
One CVE, three releases, three defensible ratings driven by each release's architecture.

This is why per-release context is the only honest way to score. A finding that is unreachable in the shipped v2.0 because a service was removed is genuinely not affected there, even if the same CVE is critical in v2.4 where the feature came back. Score the product as one blob and you will be wrong in both directions.

The unit of context is the release

Every finding, rating, clock, and metric should be scoped to a release. When a finding moves between releases, it should carry forward as a clone with its own context, not a copy-paste of a rating that no longer applies. That is what makes postmarket metrics like time-to-remediation meaningful instead of misleading.

If your tool gives one product one score, it is telling you a comfortable fiction.
← All intelligence
Get started

See your device through ELTON.

Start with one device. We build the twin from documentation your quality system already produces, run AI discovery remotely, and show you the graph: the handful to fix, and the evidence for everything else.

Proof Over Probability

The AI testing newsletter.

One issue a month on AI, exploitability, and FDA cybersecurity review. No spam, unsubscribe anytime.

Questions

Common questions about per-release vulnerability context.

Can the same CVE have different severity in different releases of a product?

Yes, and all of the ratings can be correct. Severity depends on the architecture, the controls and the attack surface of the specific release the vulnerability lands in. A finding that is unreachable in a shipped v2.0 because a service was removed is genuinely not affected there, even if the same CVE is critical in v2.4.

What is wrong with one severity score per product?

Score the product as one blob and you will be wrong in both directions, inflating findings that a given release already mitigates and hiding findings another release genuinely exposes. If a tool gives one product one score, it is telling you a comfortable fiction.

What should a vulnerability finding be scoped to?

The release. Every finding, rating, clock and metric belongs to a specific release, because the release is the unit of context that decides whether a vulnerability is exploitable at all. Per-release context is the only honest way to score a connected product.

What happens to a finding when it moves between releases?

It should carry forward as a clone with its own context, not a copy-paste of a rating that no longer applies. The new release has its own architecture and attack surface, so the finding gets judged against those rather than inheriting a verdict from a version it no longer describes.

Do per-release ratings change how postmarket metrics work?

Yes. Scoping every finding, rating and clock to a release is what makes measures like time-to-remediation meaningful instead of misleading. A clock that runs across a whole product family mixes versions where the finding mattered with versions where it never applied.

Exploitability management for medical devices. FDA §524B methodologyExploitability proven at runtime95% faster than legacy testing Book a Demo
Platform
OverviewAvoid FDA DeficienciesAvoid Consulting FeesDigital Twin TraceabilityAI PentestingExploitability VerificationVulnerability ChainingRemediation OptimizationRemote TestLink™Incident ResponseAutomated VEX & MetricsCVSSv4 Migration
Solutions
Postmarket SurveillanceIncident ResponseSecurity EngineeringRegulatory AffairsFDA §524BEU MDR/CRAEU REDNIS2IMDRF N60 / N73Japan MHLW
Why ELTON
Subscription TestingAI-NativeFDA ComplianceVerified ExploitabilityELTON vs. Legacy TestingThreat-Led AI PentestingMDDT MethodologyCredentialsDevice ModalitiesPricing
Resources
FDA Deficiency ListFDA Testing RequirementsFDA Cyber SOPs & TemplatesRemediation LibraryRegulatory GuidesWebinarsAI NewsletterThe End of Legacy TestingThe AI Vulnerability ExplosionSecurity AdvisoriesWhitepapersIntelligence & Blog
Company
AboutLeadershipCareersPartnershipsContact Meet ELTON